| 2017 | Once-daily dosing of amikacin for treatment of Mycobacterium abscessus lung disease | INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE |
| 2017 | Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype | EUROPEAN RESPIRATORY JOURNAL |
| 2017 | Cellular inhibitor of apoptosis protein 2 promotes the epithelial-mesenchymal transition in triple-negative breast cancer cells through activation of the AKT signaling pathway
| ONCOTARGET |
| 2017 | NLRP3 Inflammasome Contributes to Lipopolysaccharide-induced Depressive-Like Behaviors via Indoleamine 2,3-dioxygenase Induction
| INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY |
| 2017 | Advanced glycation end products impair NLRP3 inflammasome-mediated innate immune responses in macrophages | JOURNAL OF BIOLOGICAL CHEMISTRY |
| 2017 | How Long Does Antimycobacterial Antibiotic-loaded Bone Cement Have In Vitro Activity for Musculoskeletal Tuberculosis? | CLINICAL ORTHOPAEDICS AND RELATED RESEARCH |
| 2017 | Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice
| Clinical and Vaccine Immunology |
| 2017 | Changes in Serum IgA Antibody Levels against the Glycopeptidolipid Core Antigen during Antibiotic Treatment of Mycobacterium avium Complex Lung Disease
| JAPANESE JOURNAL OF INFECTIOUS DISEASES |
| 2017 | Aminated nanomicelles as a designer vaccine adjuvant to trigger inflammasomes and multiple arms of the innate immune response in lymph nodes
| INTERNATIONAL JOURNAL OF NANOMEDICINE |
| 2017 | Down-Regulation of Serum High-Mobility Group Box 1 Protein in Patients with Pulmonary Tuberculosis and Nontuberculous Mycobacterial Lung Disease.
| TUBERCULOSIS AND RESPIRATORY DISEASES |
| 2016 | Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance | ARCHIVES OF PHARMACAL RESEARCH |
| 2016 | Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2016 | Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2016 | Selective and Efficient Elimination of Vibrio cholerae with a Chemical Modulator that Targets Glucose Metabolism
| FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY |
| 2016 | Mycobacterium abscessus D-alanyl-D-alanine dipeptidase induces the maturation of dendritic cells and promotes Th1-biased immunity
| BMB REPORTS |
| 2016 | Implication of vitamin D-associated factors in patients with non-tuberculous mycobacterial lung disease | INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE |
| 2016 | Serum inflammatory profiles in pulmonary tuberculosis and their association with treatment response | JOURNAL OF PROTEOMICS |
| 2016 | Clinical characteristics and treatment outcomes of pulmonary disease caused by Mycobacterium chimaera | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE |
| 2016 | Oral Macrolide Therapy Following Short-term Combination Antibiotic Treatment of Mycobacterium massiliense Lung Disease | CHEST |
| 2016 | Do Helper T Cell Subtypes in Lymphocytic Thyroiditis Play a Role in the Antitumor Effect?
| JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE |
